|Title:||Bisulfate salt of HIV protease inhibitor|
|Abstract:||The present invention provides the crystalline bisulfate salt of the formula ##STR1## which is found to have unexpectedly high solubility/dissolution rate and oral bioavailability relative to the free base form of this azapeptide HIV protease inhibitor compound.|
|Inventor(s):||Singh; Janak (Lawrenceville, NJ), Pudipeddi; Madhusudhan (Plainsboro, NJ), Lindrud; Mark D. (Basking Ridge, NJ)|
|Assignee:||Bristol-Myers Squibb Company (Princeton, NJ)|
1. The bisulfate salt having the formula ##STR5##
2. A pharmaceutical dosage form comprising the bisulfate salt of claim 1 and a pharmaceutically acceptable carrier.